23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
3.150
-0.280 (-8.16%)
At close: Nov 20, 2024, 4:00 PM
3.180
+0.030 (0.95%)
Pre-market: Nov 21, 2024, 7:28 AM EST
23andMe Holding Co. Employees
As of March 31, 2024, 23andMe Holding Co. had 582 total employees, including 560 full-time and 22 part-time employees. The number of employees decreased by 234 or -28.68% compared to the previous year.
Employees
582
Change (1Y)
-234
Growth (1Y)
-28.68%
Revenue / Employee
$332,062
Profits / Employee
-$1,057,239
Market Cap
86.10M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 582 | -234 | -28.68% |
| Mar 31, 2023 | 816 | 48 | 6.25% |
| Mar 31, 2022 | 768 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| P3 Health Partners | 400 |
| MDxHealth | 300 |
| Rockwell Medical | 237 |
| OptimizeRx | 136 |
| Chimerix | 72 |
| Werewolf Therapeutics | 47 |
| Quince Therapeutics | 32 |
| Clearside Biomedical | 30 |
ME News
- 1 day ago - 23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation - GlobeNewsWire
- 8 days ago - 23andMe Holding Co. (ME) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - 23andMe cuts 40% of staff in restructuring - TechCrunch
- 8 days ago - What's happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA testing company - Fast Company
- 8 days ago - 23andMe reports sales decline day after announcing plans to cut 40% of workforce - CNBC
- 8 days ago - Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles - The Guardian
- 9 days ago - 23andMe's stock turns lower after company posts its latest quarterly loss - Market Watch
- 9 days ago - 23andMe Lays Off 40% of Staff, Shuts Drug Development Business - WSJ